Literature DB >> 9430798

The reproducibility of cardiac baroreceptor activity assessed non-invasively by spectral sequence techniques.

S L Dawson1, T G Robinson, J H Youde, M A James, A Martin, P Weston, R Panerai, J F Potter.   

Abstract

Baroreceptor sensitivity (BRS) is increasingly used as a prognostic indicator in cardiovascular disease. Traditionally it has been measured using invasive techniques with pharmacological manipulation of blood pressure (BP). With the advent of newer methods to measure pulse interval and beat-to-beat changes in BP it is now possible, using sophisticated mathematical modelling techniques, to calculate cardiac BRS non-invasively. However, there are virtually no data on the reproducibility of these newer techniques and what factors may affect the repeatability of these measurements. We studied 39 subjects, aged 22-82 years, with a supine systolic BP range 97-160 mmHg and a diastolic BP range 57-94 mmHg on two occasions between 1 week and 6 months apart. Cardiac BRS was measured by power spectral analysis using Fast Fourier Transformation (FFT), sequence analysis (using up, down and combined sequences) and from phase IV of the Valsalva manoeuvre. There was no significant difference between visits for any of the methods for measuring cardiac BRS. Mean BRS values were similar for FFT (16.7 +/- 11.2 ms/mmHg) and sequence analysis (15.8 +/- 11.4 ms/mmHg); however, results using phase IV of the Valsalva manoeuvre were significantly lower (8.1 +/- 2.9 ms/mmHg, p < 0.0001). The coefficient of variation for the five measures of cardiac BRS varied from 16.8% for Valsalva-derived values to 26.1% for 'down' sequence analysis. However, in ten subjects BRS could not be calculated from the Valsalva manoeuvre. None of the independent variables tested (including age, BP levels and time between testing) significantly influenced the degree of repeatability. In summary, there appears to be little difference between these non-invasive methods in their degree of reproducibility. These techniques would seem suitable for longitudinal studies of changes in cardiac BRS and overcome many of the problems associated with the invasive pharmacological methods.

Entities:  

Mesh:

Year:  1997        PMID: 9430798     DOI: 10.1007/bf02267718

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  24 in total

1.  Evaluation of reproducibility of spontaneous baroreflex sensitivity at rest and during laboratory tests.

Authors:  F Iellamo; J M Legramante; G Raimondi; F Castrucci; M Massaro; G Peruzzi
Journal:  J Hypertens       Date:  1996-09       Impact factor: 4.844

2.  Can sinoaortic baroreceptor heart rate reflex sensitivity be determined from phase IV of the Valsalva manoeuvre?

Authors:  S A Smith; T J Stallard; M M Salih; W A Littler
Journal:  Cardiovasc Res       Date:  1987-06       Impact factor: 10.787

3.  Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity.

Authors:  H S Smyth; P Sleight; G W Pickering
Journal:  Circ Res       Date:  1969-01       Impact factor: 17.367

4.  Effect of age and high blood pressure on baroreflex sensitivity in man.

Authors:  B Gribbin; T G Pickering; P Sleight; R Peto
Journal:  Circ Res       Date:  1971-10       Impact factor: 17.367

5.  Continuous non-invasive blood pressure monitoring: reliability of Finapres device during the Valsalva manoeuvre.

Authors:  B P Imholz; G A van Montfrans; J J Settels; G M van der Hoeven; J M Karemaker; W Wieling
Journal:  Cardiovasc Res       Date:  1988-06       Impact factor: 10.787

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 7.  Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal.

Authors:  G Parati; J P Saul; M Di Rienzo; G Mancia
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

8.  Variability of the haemodynamic responses to laboratory tests employed in assessment of neural cardiovascular regulation in man.

Authors:  G Parati; G Pomidossi; A Ramirez; B Cesana; G Mancia
Journal:  Clin Sci (Lond)       Date:  1985-11       Impact factor: 6.124

9.  Baroreceptor reflex sensitivity index derived from Phase 4 of te Valsalva maneuver.

Authors:  H A Palmero; T F Caeiro; D J Iosa; J Bas
Journal:  Hypertension       Date:  1981 Nov-Dec       Impact factor: 10.190

10.  Estimation of sinoaortic baroreceptor heart rate reflex sensitivity and latency in man: a new microcomputer assisted method of analysis.

Authors:  S A Smith; T J Stallard; W A Littler
Journal:  Cardiovasc Res       Date:  1986-12       Impact factor: 10.787

View more
  5 in total

Review 1.  Predicting cardiovascular risk--the madness is in the methods.

Authors:  Mark W Chapleau
Journal:  Clin Auton Res       Date:  2005-02       Impact factor: 4.435

2.  Reproducibility of methods for assessing baroreflex sensitivity and temporal QT variability in end-stage renal disease and healthy subjects.

Authors:  Sinsia A Gao; Mats Johansson; Anna Hammarén; Martin Nordberg; Peter Friberg
Journal:  Clin Auton Res       Date:  2005-02       Impact factor: 4.435

3.  Baroreflex sensitivity measured by spectral and sequence analysis in cerebrovascular disease : methodological considerations.

Authors:  Paul Johnson; Angela Shore; John Potter; Ronney Panerai; Martin James
Journal:  Clin Auton Res       Date:  2006-06-12       Impact factor: 5.625

4.  Advances in the cardiovascular assessment of patients with chronic kidney disease.

Authors:  Chris W McIntyre; Stephen G John; Helen J Jefferies
Journal:  NDT Plus       Date:  2008-09-08

5.  The Stability and Repeatability of Spontaneous Sympathetic Baroreflex Sensitivity in Healthy Young Individuals.

Authors:  Sarah L Hissen; Khadigeh El Sayed; Vaughan G Macefield; Rachael Brown; Chloe E Taylor
Journal:  Front Neurosci       Date:  2018-06-14       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.